이종우 교수
전문진료분야
간, 담낭, 담도 및 췌장종양, 담석증, 담낭염, 복강경 및 로봇수술
전화 예약
1577-1801
기본정보
학력
한양대학교 의과대학 학사 울산대학교 의과대학 석사 울산대학교 의과대학 박사 |
경력
서울아산병원 수련의 서울아산병원 외과 전공의 서울아산병원 간담도췌외과 전임의 간담췌외과 분과전문의 한림대학교성심병원 외과 조교수 |
학회활동
대한내시경복강경외과학회 평생회원 대한외과학회 평생회원 한국췌장외과연구회 정회원 최소침습췌장수술연구회 정회원 한국간담췌외과학회 평생회원 |
논문
Impact of Modified Blumgart Anastomosis on Pancreatic Fistula and Pancreaticojejunostomy Time During Laparoscopic Pancreaticoduodenectomy: Single-Center Experience (Journal of Clinical Medicine)
Oncologic and Long-Term Outcomes of Laparoscopic and Open Extended Cholecystectomy for Gallbladder Cancer (Journal of Clinical Medicine)
Prognostic Impact of Perioperative CA19-9 Levels in Patients with Resected Perihilar Cholangiocarcinoma (JOURNAL OF CLINICAL MEDICINE)
Prognostic Impact of Perioperative CA19-9 Levels in Patients with Resected Perihilar Cholangiocarcinoma (JOURNAL OF CLINICAL MEDICINE)
Risk factors of posthepatectomy liver failure for perihilar cholangiocarcinoma Risk score and significance of future liver remnant volume-to-body weight ratio (JOURNAL OF SURGICAL ONCOLOGY)
Prognostic Predictability of American Joint Committee on Cancer 8th Staging System for Perihilar Cholangiocarcinoma: Limited Improvement Compared with the 7th Staging System (Cancer Research and Treatment)
Oncologic and Long-Term Outcomes of Laparoscopic and Open Extended Cholecystectomy for Gallbladder Cancer (Journal of Clinical Medicine)
Prognostic Impact of Perioperative CA19-9 Levels in Patients with Resected Perihilar Cholangiocarcinoma (JOURNAL OF CLINICAL MEDICINE)
Prognostic Impact of Perioperative CA19-9 Levels in Patients with Resected Perihilar Cholangiocarcinoma (JOURNAL OF CLINICAL MEDICINE)
Risk factors of posthepatectomy liver failure for perihilar cholangiocarcinoma Risk score and significance of future liver remnant volume-to-body weight ratio (JOURNAL OF SURGICAL ONCOLOGY)
Prognostic Predictability of American Joint Committee on Cancer 8th Staging System for Perihilar Cholangiocarcinoma: Limited Improvement Compared with the 7th Staging System (Cancer Research and Treatment)